I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
T. Kadia
107
results:
Search for persons
X
Format
Online (107)
Mediatypes
Articles (Online) (48)
OpenAccess-fulltext (59)
Languages
english (92)
Sorted by: Relevance
Sorted by: Year
?
1
Immunotherapy: CXCR4 ENRICHED UMBILICAL CORD BLOOD DERIVED ..:
Huang, M.
;
Zeng, K.
;
Lyu, M.
...
Cytotherapy. 25 (2023) 6 - p. S246-S247 , 2023
Link:
https://doi.org/10.1016/..
?
2
S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADEL..:
Short, N.
;
Kantarjian, H.
;
Konopleva, M.
...
HemaSphere. 6 (2022) - p. 15-16 , 2022
Link:
https://doi.org/10.1097/..
?
3
S127: QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) ..:
Yilmaz, M.
;
Muftuoglu, M.
;
Kantarjian, H.
...
HemaSphere. 6 (2022) - p. 28-29 , 2022
Link:
https://doi.org/10.1097/..
?
4
P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WI..:
Bazinet, A.
;
Jabbour, E.
;
Kantarjian, H.
...
HemaSphere. 6 (2022) - p. 652-653 , 2022
Link:
https://doi.org/10.1097/..
?
5
P497: PROGNOSTIC IMPACT OF RAS AND C-KIT MUTATIONS (SINGLE ..:
Abuasab, T.
;
Senapati, J.
;
Kadia, T.
...
HemaSphere. 6 (2022) - p. 396-397 , 2022
Link:
https://doi.org/10.1097/..
?
6
P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNO..:
Haddad, F.
;
Sasaki, K.
;
Abuasab, T.
...
HemaSphere. 6 (2022) - p. 440-441 , 2022
Link:
https://doi.org/10.1097/..
?
7
P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ..:
Venugopal, S.
;
kantarjian, H.
;
Maiti, A.
...
HemaSphere. 6 (2022) - p. 679-680 , 2022
Link:
https://doi.org/10.1097/..
?
8
P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZ..:
Kadia, T.
;
Ravandi, F.
;
Borthakur, G.
...
HemaSphere. 6 (2022) - p. 1080-1081 , 2022
Link:
https://doi.org/10.1097/..
?
9
P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE ..:
Bazinet, A.
;
Kadia, T.
;
Short, N.
...
HemaSphere. 6 (2022) - p. 405-406 , 2022
Link:
https://doi.org/10.1097/..
?
10
P767: CLINICAL SIGNIFICANCE OF ROUTINE HIGH-RESOLUTION STRU..:
Yang, H.
;
Garcia-Manero, G.
;
Sasaki, K.
...
HemaSphere. 6 (2022) - p. 662-663 , 2022
Link:
https://doi.org/10.1097/..
?
11
P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGI..:
Ravandi, F.
;
Jabbour, E.
;
Jain, N.
...
HemaSphere. 6 (2022) - p. 265-266 , 2022
Link:
https://doi.org/10.1097/..
?
12
P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY ..:
Macaron, W.
;
Jabbour, E.
;
Konopleva, M.
...
HemaSphere. 6 (2022) - p. 272-273 , 2022
Link:
https://doi.org/10.1097/..
?
13
P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THE..:
Kim, K.
;
Ong, F.
;
Li, Z.
...
HemaSphere. 6 (2022) - p. 665-666 , 2022
Link:
https://doi.org/10.1097/..
?
14
P769: MUTATION PROFILES AND RISK STRATIFICATION IN HYPOCELL..:
Kim, K.
;
Chien, K.
;
Faustine, O.
...
HemaSphere. 6 (2022) - p. 664-665 , 2022
Link:
https://doi.org/10.1097/..
?
15
P496: CLINICAL CHARACTERISTICS OF SECONDARY MYELOID NEOPLAS..:
Abuasab, T.
;
Mohadam, S. F.
;
Hwang, H.
...
HemaSphere. 6 (2022) - p. 395-396 , 2022
Link:
https://doi.org/10.1097/..
1-15